102 related articles for article (PubMed ID: 6692356)
1. Hematological toxicity of repeated injections of (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea.
Rebischung JL; Gougeon MD; Mori KJ; Lemaigre G; Mathé G; Jasmin C
Cancer Res; 1984 Feb; 44(2):503-6. PubMed ID: 6692356
[TBL] [Abstract][Full Text] [Related]
2. In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.
Mori KJ; Jasmin C; Hayat M; MacDonald JS; Mathé G
Cancer Res; 1980 Nov; 40(11):4282-6. PubMed ID: 6451285
[No Abstract] [Full Text] [Related]
3. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
[TBL] [Abstract][Full Text] [Related]
4. Hematologic effects of a single dose of methylnitrosourea.
Seidel HJ
Exp Hematol; 1977 Jan; 5(1):19-26. PubMed ID: 832681
[TBL] [Abstract][Full Text] [Related]
5. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
[TBL] [Abstract][Full Text] [Related]
6. In vivo acute hematotoxicity of N,N'-bis[N-(2-chloroethyl)-N-nitrosocarbamoyl]cystamine (CNCC), a new nitrosourea analog.
Blazsek I; Mathé G; Maral R; Jasmin C
Toxicol Appl Pharmacol; 1984 Jun; 74(2):250-7. PubMed ID: 6740675
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
8. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice.
Pruijt JF; Lindley IJ; Heemskerk DP; Willemze R; Fibbe WE
Stem Cells; 1997; 15(1):50-5. PubMed ID: 9007222
[TBL] [Abstract][Full Text] [Related]
9. Effects of high-dose methotrexate and leucovorin on murine hemopoietic stem cells.
Pannacciulli I; Massa G; Bogliolo G; Ghio R; Sobrero A
Cancer Res; 1982 Feb; 42(2):530-4. PubMed ID: 6976827
[TBL] [Abstract][Full Text] [Related]
10. Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite.
Soderberg LS; Flick JT; Barnett JB
Exp Hematol; 1996 Jun; 24(7):848-53. PubMed ID: 8647236
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice.
Maestroni GJ; Covacci V; Conti A
Cancer Res; 1994 May; 54(9):2429-32. PubMed ID: 8162592
[TBL] [Abstract][Full Text] [Related]
12. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
van Os R; Robinson S; Sheridan T; Mauch PM
Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384
[TBL] [Abstract][Full Text] [Related]
14. Enhanced proliferation of functionally competent bone marrow cells in different strains of mice treated with swainsonine.
Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; White SL; Olden K; Parish-Gause D; Vaughn T; Griffin WM; Sridhar R
Int Immunopharmacol; 2003 Mar; 3(3):445-55. PubMed ID: 12639822
[TBL] [Abstract][Full Text] [Related]
15. Hemopoietic activity in bone marrow chimeras prepared with total lymphoid irradiation (TLI).
Slavin S; Seidel HJ
Exp Hematol; 1982 Feb; 10(2):206-16. PubMed ID: 7037437
[TBL] [Abstract][Full Text] [Related]
16. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
[TBL] [Abstract][Full Text] [Related]
17. General 4-week toxicity study with EMS in the rat.
Pfister T; Eichinger-Chapelon A
Toxicol Lett; 2009 Nov; 190(3):271-85. PubMed ID: 19442710
[TBL] [Abstract][Full Text] [Related]
18. Myeloprotective effect of diethyldithiocarbamate treatment following 1,3-bis(2-chloroethyl)-1-nitrosourea, adriamycin, or mitomycin C in mice.
Schmalbach TK; Borch RF
Cancer Res; 1989 May; 49(10):2574-7. PubMed ID: 2540902
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity studies of Ethylene Glycol Ethers: 2-Methoxyethanol, 2-Ethoxyethanol, 2-Butoxyethanol (CAS Nos. 109-86-4, 110-80-5, 111-76-2) Administered in Drinking Water to F344/N Rats and B6C3F1 Mice.
Dieter M
Toxic Rep Ser; 1993 Jul; 26():1-G15. PubMed ID: 12209180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
